FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/109000 [Registered on: 21/04/2026] Trial Registered Prospectively
Last Modified On: 10/06/2026
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Effect of an Integrated Care Model Incorportaing Meditation in the Management of Stage I Hypertension 
Scientific Title of Study   EVALUATION OF THE THERAPEUTIC EFFECTIVENESS OF AN INTEGRATED CARE MODEL INCORPORATING MEDITATION IN THE MANAGEMENT OF STAGE I HYPERTENSION. AN OBSERVATIONAL CLINICAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ajay Singh 
Designation  Resident Medical Officer 
Affiliation  Patanjali Wellness 
Address  OPD No 17 Department of Panchkarma Patanjali Wellness Delhi Haridwar National Highway Near Bahadrabad Haridwar

Hardwar
UTTARANCHAL
249405
India 
Phone  9039402300  
Fax    
Email  drajaysingh82@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ajay Singh 
Designation  Resident Medical Officer 
Affiliation  Patanjali Wellness 
Address  OPD No 17 Department of Panchkarma Patanjali Wellness Delhi Haridwar National Highway Near Bahadrabad Haridwar


UTTARANCHAL
249405
India 
Phone  9039402300  
Fax    
Email  drajaysingh82@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ajay Singh 
Designation  Resident Medical Officer 
Affiliation  Patanjali Wellness 
Address  OPD No 17 Department of Panchkarma Patanjali Wellness Delhi Haridwar National Highway Near Bahadrabad Haridwar


UTTARANCHAL
249405
India 
Phone  9039402300  
Fax    
Email  drajaysingh82@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Research Foundation Governed by Patanjali Research Foundation Trust NH 58 Near Bahadrabad Haridwar Uttarakhand 249405 India 
 
Primary Sponsor  
Name  Patanjali Research Foundation 
Address  NH 58 Near Bahadrabad Haridwar Uttarakhand 249405 India 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ajay Singh  Patanjali Wellness  OPD No 17 Department of Panchkarma Patanjali Wellness Delhi Haridwar National Highway Near Bahadrabad Haridwar
Hardwar
UTTARANCHAL 
9039402300

drajaysingh82@gmail.com 
Dr Anurag Sharma  Patanjali Yoggram  OPD No 13 Department of Panchkarma Patanjali Yoggram Yog Naturopathy Panchkarma Treatment and Research Centre Yoggram Village Aurangabad Near SIDCUL Roshnabad Haridwar
Hardwar
UTTARANCHAL 
8171510464

dr.anuragsharma1987@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
PATANJALI AYURVED COLLEGE ETHICS COMMITTEE  Approved 
PATANJALI AYURVED COLLEGE ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I10||Essential (primary) hypertension. Ayurveda Condition: RAKTAVRUTAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients with Stage 1 Hypertension. (SBP 140-145 mm Hg, DBP 90-95 mm Hg)

The subject is able and willing to provide consent
 
 
ExclusionCriteria 
Details  Pregnant or lactating women, plaaning for pregnancy
Uncontrolled HTN, Stage 2 HTN
Any condition that investigator identifies can confound the participant ability to participate in the study 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Change in SBP/DBP   Baseline (Day 1) to Day 15 
 
Secondary Outcome  
Outcome  TimePoints 
• Changes in World Health Organization Quality of Life assessment instrument (WHOQOL-BREF)   Baseline (Day 1) to Day 15 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study aims to investigate and interpretation of the effectiveness assessment of an Integrative Care Model Incorporating Meditation in the Management of Elevated and Stage 1 Hypertension. By assessing the effectiveness of this integrated approach, we seek to contribute to the growing body of evidence on complementary and alternative approaches to blood pressure management, ultimately improving outcomes and quality of life for individuals living with Elevated and Stage 1 Hypertension.

 
Close